Preclinical development of siRNA therapeutics: Towards the match between fundamental science and engineered systems

This review discusses recent progress and pertinent limiting factors related to the use of siRNA-s as efficient protein-specific “silencing” agents, focusing on targeted delivery not only to cells of interest, but to the proper intracellular destination.